Bon Secours Hospital Cork

At Bon Secours Hospital Cork, research in Medical Oncology focuses strongly on breast cancer, including metastatic breast cancer, triple negative breast cancer, and HR+/HER2-negative breast cancer. These studies are aimed at improving treatment effectiveness, refining adjuvant care, and testing whether new combinations can better prevent recurrence and extend survival.

• Testing new treatment combinations for metastatic breast cancer
• Evaluating therapy options for ER+/HER2-negative and hormone receptor-positive breast cancer
• Studying strategies to reduce recurrence in early breast cancer

The site is also involved in research on whether treatment can be better tailored using risk markers, helping match therapy intensity more closely to each patient’s disease profile.

Clinical trials at this hospital include a major emphasis on ovarian cancer, fallopian tube cancer, primary peritoneal cancer, and related gynecologic malignancies. The research is designed to improve maintenance treatment, delay disease progression, and assess approaches that may reduce treatment-related side effects while preserving cancer control.

• Maintenance treatment studies in platinum-sensitive ovarian cancer
• Research in recurrent ovarian cancer with specific tumor markers
• Evaluating safer and more effective options for advanced gynecologic cancers

This area reflects a broader effort to improve outcomes for women with hard-to-treat cancers by testing new therapies and supportive care approaches.

Another important focus is prostate cancer, including castration-resistant prostate cancer and localized very high-risk prostate cancer. Trials in this area are exploring ways to strengthen standard treatment, improve control of metastatic disease, and assess whether adding new therapies or radiation can better delay progression.

• Studies for castration-resistant prostate cancer with limited metastatic disease
• Research in localized very high-risk prostate cancer
• Testing treatment combinations to improve progression-free survival

The research may be especially relevant for patients whose disease is identified through advanced imaging and for those needing more personalized treatment strategies.

The trial portfolio also includes colorectal cancer, along with other solid tumors such as stomach cancer and oesophageal cancer. These studies are focused on evaluating new therapy combinations, improving disease control after surgery, and testing treatments for cancers that have spread or are difficult to remove.

• Research in unresectable or metastatic colorectal cancer
• Studies addressing recurrence after treatment for common solid tumors
• Exploring improved systemic treatment options for advanced gastrointestinal cancers

This work supports efforts to make treatment more effective across a range of gastrointestinal and solid tumor cancers.

The site’s research also covers diffuse large B-cell lymphoma and cancer-associated venous thromboembolism, showing a broader interest in both cancer treatment and complication prevention. These trials aim to improve outcomes for people with blood cancers and to find better ways to prevent dangerous clotting events in patients with active cancer.

• Evaluating new treatment options for relapsed or refractory DLBCL
• Studying prevention of venous thromboembolism in patients with cancer
• Comparing anticoagulation approaches to reduce clot recurrence

This combination of oncology and supportive care research highlights the site’s interest in both direct cancer control and safer long-term patient management.